From the Duncan Banner:
“The FDA is requiring label changes … including an updated boxed warning and Medication Guide,” stated a press release from the FDA. “The serious side effects associated with Fluoroquinolones generally outweigh the benefits for patients with sinusitis, bronchitis and uncomplicated urinary tract infections who have other treatment options. For patients with these conditions, Fluoroquinolones should be reserved for those who do not have alternative treatment options.”
Full story here: http://www.duncanbanner.com/news/fda-changes-fluoroquinolones-labels/art…
